Recently, the RA metabolizing enzyme CYP26A1 (cytochrome P450, family 26, subfamily A, polypeptide 1) has been shown to promote the survival and oncogenic potential of breast carcinoma cells, indicating a possible oncogenic function of CYP26A1 in breast carcinogenesis [13]. The gene discussed is CYP26A1; the disease is breast carcinoma.